Journal article icon

Journal article

Automation of CAR-T cell adoptive immunotherapy bioprocessing: Technology opportunities to debottleneck manufacturing

Abstract:
Continued clinical efficacy demonstrations of cell-based immunotherapies (iTx) such as chimeric antigen receptor T cell (CAR-T) therapies has made the prospect increasingly likely of an immunotherapy product achieving conditional market authorization in the short term.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Authors


Biagioni, K More by this author
Choudhary, R More by this author
Expand authors...
More from this funder
Funding agency for:
Brindley, D
More from this funder
Funding agency for:
Brindley, D
CASMI Translational Stem Cell Consortium More from this funder
Publisher:
BioProcess International Publisher's website
Journal:
BioProcess International Journal website
Publication date:
2016-04-18
Acceptance date:
2016
EISSN:
1945-7065
ISSN:
1542-6319
Pubs id:
pubs:626356
URN:
uri:9d4bec59-7310-4a8f-95c1-e66ce618dbc2
UUID:
uuid:9d4bec59-7310-4a8f-95c1-e66ce618dbc2
Local pid:
pubs:626356
Keywords:

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP